Skip to main content

Innovations

The PSNet Innovations page highlights pioneering advances that can improve patient safety. PSNet innovations are defined as “new or updated interventions, approaches, systems, tools, policies, organizational structures or business models implemented to improve or enhance quality of care and reduce harm.” The PSNet Innovations page includes innovations developed, tested, and sustained within the past five years, updates to existing innovations that were featured in AHRQ’s Health Care Innovations Exchange, as well as “emerging innovations,” which are new, novel approaches to patient safety improvement recently published in the peer-reviewed literature.

Read more about how PSNet Innovations can be used.

PSNet innovations can be used to:

  • Identify new tactics, strategies, tools, or approaches that could be implemented by a broader audience
  • Learn about recent innovations with promising early results
  • Consider conditions that support the successful implementation or sustainment of an innovation or an emerging innovation

Future posted innovations will be curated by the PSNet team based on their impact on the provision of health care.

Want to submit an innovation?
Have you or your organization developed, implemented, and sustained an innovation that has generated results enhancing quality of care or reducing patient harm? We want to highlight your innovation on PSNet.

Latest Innovations

Emerging Innovations

All Innovations (54)

Published Date
PSNet Publication Date
Narrow Results By
Displaying 1 - 4 of 4 Results

The Revised Safer Dx Instrument provides a standardized list of questions to help users retrospectively identify and assess the likelihood of a missed diagnosis in a healthcare episode. Results of the assessment are intended for use in system-level safety improvement efforts, clinician feedback, and patient safety research.

The Veterans Health Administration (VHA) Stratification Tool for Opioid Risk Mitigation (STORM) decision support system and targeted prevention program were designed to help mitigate risk factors for overdose and suicide among veterans who are prescribed opioids and/or with opioid use disorder (OUD) and are served by the VHA.1 Veterans, particularly those prescribed opioids, experience overdose and suicide events at roughly twice

The team at Geisinger sought to develop an outpatient addiction medicine specialty program that incorporated medication-assisted treatment (MAT), peer support, and connection to community counseling services and uses data-driven insights to monitor and improve patient outcomes. As a result of this program, they have been able to reduce all-cause mortality among these patients, increase patient engagement in substance use disorder treatment, and have seen a reduction in the prescription quantities of controlled substances.